Climate-Sensitive Disease Diagnostics
Africa · 1 shared keyword
Updated
Reviewed by Vidhi Upadhyay
Africa Rapid Antigen Tests Market Industry Trends and Forecast to 2034: Segmented by (Disease, User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$75.0 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $136.2 Mn | — | — |
| 2025 (base) | $142.8 Mn | +$6.5 Mn | — |
| 2026 (forecast) | $149.6 Mn | +$6.9 Mn | +4.8% |
| 2027 (forecast) | $156.8 Mn | +$7.2 Mn | +9.8% |
| 2028 (forecast) | $164.3 Mn | +$7.5 Mn | +15.1% |
| 2029 (forecast) | $172.2 Mn | +$7.9 Mn | +20.6% |
| 2030 (forecast) | $180.5 Mn | +$8.3 Mn | +26.4% |
| 2031 (forecast) | $189.2 Mn | +$8.7 Mn | +32.5% |
| 2032 (forecast) | $198.2 Mn | +$9.1 Mn | +38.8% |
| 2033 (forecast) | $207.8 Mn | +$9.5 Mn | +45.5% |
| 2034 (forecast) | $217.7 Mn | +$10.0 Mn | +52.5% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $142.8 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $217.7 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 4.8% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Disease and user (see all) |
| Key players | Abbott Laboratories, Quidel Corporation, Roche Diagnostics, SD Biosensor, BD (Becton, Dickinson) (see all) |
| Regulator in Africa | AMASource: African Union, African Medicines Agency treaty. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Rapid antigen tests detect proteins from viruses or bacteria in minutes, used for flu, COVID-19, strep throat and more.
Key segments of the rapid Antigen Tests market include disease (Influenza, COVID-19 and Strep A) and user (Professional and Self-Test).
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the rapid Antigen Tests market.
Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the rapid Antigen Tests market room to grow, especially in emerging markets.
Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the rapid Antigen Tests market.
The rapid Antigen Tests market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
The African Medicines Agency (AMA) treaty covers medical devices and diagnostics as well as medicines; national regulators still approve products.[1] In some of the countries we cover here, medical devices are regulated by EDA (Egypt)[2], PPB (Kenya)[3] and SAHPRA (South Africa)[4]. How care is paid for in some of these countries: universal health insurance (Egypt)[5], the SHA (Kenya)[6] and planned National Health Insurance (South Africa)[7].
[1] African Union, African Medicines Agency treaty. Checked 14 Nov 2026.
[2] Egyptian Drug Authority. Checked 14 Nov 2026.
[3] Pharmacy and Poisons Board. Checked 14 Nov 2026.
[4] South African Health Products Regulatory Authority. Checked 14 Nov 2026.
[5] Universal Health Insurance Authority. Checked 14 Nov 2026.
[6] Social Health Authority. Checked 14 Nov 2026.
[7] National Department of Health. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how rapid Antigen Tests products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Africa.
What doctors and scientists are doing in Rapid Antigen Tests right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
Africa · 1 shared keyword
Africa
Africa
Africa
Africa
Africa
Public Health · Africa
Public Health · Africa
Digital Health · Africa
Healthcare Services · Africa
Pharmaceuticals · Africa
OTC & Nutraceuticals · Africa